Pharmacotherapies for Alcohol and Substance Use Disorder Alliance
Research Admin Offices:
- HRS
Funding Type:
GrantOpportunity Type:
- Grant
Value:
Up to $150,000 over nine to twelve months for RFA 7a/Planning Award.
Up to $600,000 over 18 months for RFA 7b/Pre-Clinical Award.
Up to $600,000 over 24 months for RFA 7c/Non-Clinical Award.
Disciplines:
- Health Sciences
Sponsors:
- Pharmacotherapies for Alcohol and Substance Use Disorder Alliance (PASA)
Deadlines:
Internal Deadline:
June 30, 2023Sponsor Deadline:
July 14, 2023Additional Dates:
- RFA 7a/Planning Award - LOI HRS Due Date - June 16, 2023
- RFA 7a/Planning Award - LOI Sponsor Due Date - June 30, 2023
- RFA 7a/Planning Award - Application HRS Due Date - June 30, 2023
- RFA 7a/Planning Award - Application Sponsor Due Date - July 14, 2023
- RFA 7b/Pre-Clinical Award & RFA 7c/Non-Clinical Award - LOI HRS Due Date - June 16, 2023
- RFA 7b/Pre-Clinical Award & RFA 7c/Non-Clinical Award - LOI Sponsor Due Date - June 30, 2023
- RFA 7b/Pre-Clinical Award & RFA 7c/Non-Clinical Award - Application HRS Due Date - July 14, 2023
- RFA 7b/Pre-Clinical Award & RFA 7c/Non-Clinical Award - Application Sponsor Due Date - July 28, 2023
Description:
These opportunities support scientific investigations aimed at creating novel medications that can enhance the effectiveness of treating alcohol and substance use disorders (ASUD). This focus is particularly important in relation to post-traumatic stress disorder (PTSD) and various psychological disorders.
Resources:
Contact:
If applying from the Faculty of Health Sciences, unless otherwise indicated, you no longer need to send documents to HRS Intake. Your first point of contact is your assigned Senior Grants Advisor.